What does BPC-157 cost in each channel?
Prices in US dollars at the verification date. Ranges are published list or program prices where a primary source exists; notes say when a figure is a typical market range instead.
| Channel | Price (USD) | Notes |
|---|---|---|
| With insurance | Not published | Not covered. Medicare Part D and commercial pharmacy benefits cover FDA approved drugs for accepted indications; compounded or unapproved peptides are paid in cash. [4] |
| Compounded pharmacy | Not published | No lawful compounded price. BPC-157 was withdrawn from 503A Category 2 in April 2026 and recommended for the 503A bulks list by PCAC in July 2026, but the recommendation is advisory: until FDA publishes a final rule it is not on the bulks list, and a 503A pharmacy has no federal basis to compound it from bulk. Advertised clinic prices are not a comparable price, and products sold as research chemicals are not lawful for human use. [1] [2] [3] |
What is the list price of BPC-157?
There is no list price: BPC-157 is not an FDA approved drug and is not on the 503A bulks list, so there is no lawful compounded product to price. Products sold as research chemicals are not lawful for human use and are not a comparable price.
Does insurance cover BPC-157?
Not covered by commercial plans or Medicare because it is an unapproved compounded product. Health savings account eligibility depends on a prescription and the plan administrator.
What changes the price?
- No lawful compounding basis until FDA adds the substance to the 503A bulks list by final rule
Frequently asked questions
How much does BPC-157 cost without insurance?
No lawful compounded price. BPC-157 was withdrawn from 503A Category 2 in April 2026 and recommended for the 503A bulks list by PCAC in July 2026, but the recommendation is advisory: until FDA publishes a final rule it is not on the bulks list, and a 503A pharmacy has no federal basis to compound it from bulk. Advertised clinic prices are not a comparable price, and products sold as research chemicals are not lawful for human use. [1] [2] [3]
Does insurance cover BPC-157?
Not covered by commercial plans or Medicare because it is an unapproved compounded product. Health savings account eligibility depends on a prescription and the plan administrator. [4]
What is the list price of BPC-157?
There is no list price: BPC-157 is not an FDA approved drug and is not on the 503A bulks list, so there is no lawful compounded product to price. Products sold as research chemicals are not lawful for human use and are not a comparable price.
Related pages
- BPC-157: evidence, legality, and access
- BPC-157 vs ARA-290 (cibinetide)
- BPC-157 vs GHK-Cu (GHK-Cu cost)
- BPC-157 vs KPV (KPV cost)
- BPC-157 vs TB-500 (TB-500 (thymosin beta-4) cost)
- Tendon injury and tendinopathy: peptide evidence
- Muscle recovery and injury: peptide evidence
- Wound healing: peptide evidence
- Inflammation and inflammatory bowel disease: peptide evidence
- Inflammatory bowel disease (Crohn disease and ulcerative colitis): peptide evidence
- Irritable bowel syndrome: peptide evidence
- Traumatic brain injury: peptide evidence
- Osteoarthritis: peptide evidence
- Chronic pain: peptide evidence
- Where it is legal to get: peptide law by state
- Full cost index
From the blog
- BPC-157 before and after: reviews, results, and what controlled studies show
BPC-157 reviews and before and after stories are everywhere. Controlled results exist only in rats. What the animal healing timelines show, what the human pilots found, and why anecdotes mislead.
- BPC-157 for gut health: the animal evidence and the missing human trials
BPC-157 healed ulcers, colitis, fistulas, and short bowel in rats. No human gut trial has published results. What the GI studies found, what is missing, and what has human evidence.
- BPC-157 human studies: every published report and registered clinical trial
Every published BPC-157 human report, with sample size and limits, plus every registered clinical trial on ClinicalTrials.gov. About 30 people, no control groups, and no randomized results yet.
- BPC-157 nasal spray: what is and is not known about intranasal use
No published study has given BPC-157 as a nasal spray to animals or people. What the one nose-related rat study tested, what a nasal peptide must prove, and its legal status.
- Oral BPC-157: what capsules and pills were tested for, and what is missing
Oral BPC-157 worked in rat gut, ligament, and fistula studies. No study has measured how much an oral capsule absorbs in people, and the two registered oral studies have posted no results.
- Peptides for tendon recovery, ranked by human evidence
BPC-157, TB-500, GHK-Cu, PEG-MGF, and IGF-1 LR3 ranked by our evidence grades. None has a published human tendon trial. Here is the ranking, the reasoning, and what does have human data.
Sources
- [1]FDA: July 23-24, 2026 meeting of the Pharmacy Compounding Advisory Committee (BPC-157, KPV, TB-500, MOTS-c, DSIP, semax, epitalon)FDA
- [2]FDA: Bulk drug substances used in compounding under section 503A of the FD&C Act (links to the Category 1, 2, and 3 lists and the bulks list)FDA
- [3]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (Category 2 list and withdrawn nominations, content current as of April 22, 2026)FDA
- [4]Medicare.gov: prescription drug coverage (Part D and outpatient drugs)